The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
AllAfrica on MSN5h
We Had Already Planned to Take Over - Says Govt On Health Sector Following Trump's 'Unexpected' OrdersSTRUGGLING to provide basics at public hospitals, government has sensationally claimed it had already decided to 'takeover' the health sector before American President Donald Trump's unexpected ...
The rollback of funding for anti-malaria efforts in the Mekong is just one of many examples of cuts that are raising alarm ...
In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback